Scientists have developed a device that electronically stimulates tear production, which will offer hope to sufferers of dry eye syndrome, one of the most common eye diseases in the world.
The device, 16 mm long, 3-4 mm wide and 1-2 mm thick, was implanted beneath the inferior lacrimal gland in rabbit eyes. It was activated wirelessly, and shown to increasing the generation of tears by nearly 57%.
The results are published today, Dec. 11, 2015, in the Journal of Neural Engineering.
“I’ve been working on electro-neural interfaces for about a decade, but the idea to stimulate lacrimal gland for tear production came from my postdoctoral fellow, Michael Ackermann.” Says Professor Daniel Palanker, an author on the study, from Stanford University.
‘Dry eye’ — deficiency of the tear film on the surface of the cornea leading to inflammation of the cornea and conjunctiva — is one of the most common eye disease, affecting 5-6% of the population, and nearly 5 million individuals aged over 65 in the United States. Currently it does not have an effective treatment.
The researchers also discovered that the afferent neural pathway — the neural pathway from sensory neurons to the brain which activates the reflex tearing — offered an even more efficient way to enhance tear production.
“Initially we only planned to stimulate the lacrimal gland” continues Palanker. “The biggest surprise for us was discovering that stimulating the afferent neural pathway provided a more potent and long-lasting tear response.”
The next phase of the research will be to evaluate the ‘quality’ of the tears produced, as in addition to volume, protein and lipid content are important. The device is currently undertaking clinical trials for FDA approval.
“I hope to see it on the market in the next year” concludes Palanker. “Meanwhile, we’re continuing research into the mechanisms of the tearing response, its enhancement and quality of the tears produced by neural stimulation.”
The Latest on: Dry eye
[google_news title=”” keyword=”Dry eye” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Dry eye
- Latin America Dry Eye Syndrome Market Share, Industry Growth Analysis, Revenue, Size, Report 2024-2032on February 28, 2024 at 10:11 pm
IMARC Group's report titled“ Latin America Dry Eye Syndrome Market Report by Disease Type (Evaporative, Aqueous), Drug Type (Anti-inflammat ...
- Why ageing causes eye problems and diseases in the elderlyon February 28, 2024 at 10:03 pm
Here are a few eye issues that affect people over the age of 50. When the tear glands cannot generate enough tears or produce tears of poor quality, dry eyes result. The disorder may cause burning, ...
- Palatin’s stock plummets 43% as lead asset fails PhIII dry eye co-primary endpointson February 28, 2024 at 8:02 am
Although Palatin Technologies' lead drug candidate missed a pair of primary endpoints in a Phase III dry eye disease trial, the company believes there’s still a future for the asset after further ...
- Palatin CEO claims 'a positive study on its face,' despite dry eye drug's primary endpoint misson February 28, 2024 at 6:25 am
CEO Carl Spana, Ph.D, spun the results as a positive on a Wednesday morning conference call, pointing to an analysis that considered age and sex that showed statistical significance on the primary ...
- Palatin Technologies Shares Tumble Premarket on Dry-Eye Study Resultson February 28, 2024 at 4:46 am
By Colin Kellaher Palatin Technologies shares slid nearly 40% in premarket trading Wednesday after the biopharmaceutical company reported mixed ...
- Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)on February 28, 2024 at 4:30 am
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...
- Thousands of ointments for dry eyes sold in CVS and Walmart are recalled nationwide due to infection riskon February 27, 2024 at 4:13 pm
No infections have been recorded to date.It comes after four Americans died after using eyedrops laced with a drug-resistant bacteria that were also supplied to the US from India.In the previous ...
- This Serum From a Victoria Beckham-Used Brand Is the Only Under-Eye Product I Repeat-Buyon February 26, 2024 at 4:00 pm
My interest in Osea was sparked by a friend with excellent taste in skincare. After procuring a host of its bestsellers, including its body oil — which is used by the likes of Victoria Beckham and ...
- Here's what you should know about 'cherry eye,' a malady in dogs that causes red spoton February 26, 2024 at 4:00 am
An untreated cherry eye can also result in damage to the tear duct and cause chronic dry eye. In addition, the gland may become increasingly swollen over time and restrict blood flow. This can be ...
- Japan's Asahi eyes overseas M&A to quadruple sales of Super Dry beeron February 26, 2024 at 12:40 am
Japan's Asahi Group Holdings is on the hunt for acquisition targets in the United States and elsewhere to quadruple overseas sales of its flagship Super Dry beer by 2030, its chief executive said.The ...
via Bing News